The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference.
about
A role for brain stress systems in addiction.A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administrationThe nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medicationsAmygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD.Stress modulation of drug self-administration: implications for addiction comorbidity with post-traumatic stress disorder.Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward.Inhibition of phosphodiesterase10A attenuates morphine-induced conditioned place preference.BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.The Nociceptin Receptor as an Emerging Molecular Target for Cocaine AddictionThe effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeysDifferential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors.Agonist-antagonist combinations in opioid dependence: a translational approachIn vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptorNovel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney 293 cells coexpressing κ-, μ-opioid and nociceptin receptors.Activities of mixed NOP and mu-opioid receptor ligands.Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in miceRetrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activityNociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.Extinction of morphine-dependent conditioned behavior is associated with increased phosphorylation of the GluR1 subunit of AMPA receptors at hippocampal synapses.Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applicationsNociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.Preclinical evidence of new opioid modulators for the treatment of addiction.Combined action of MK-801 and ceftriaxone impairs the acquisition and reinstatement of morphine-induced conditioned place preference, and delays morphine extinction in rats.Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)Critical evaluation of the use of extinction paradigms for the assessment of opioid-induced conditioned place preference in rats.TH-030418: a potent long-acting opioid analgesic with low dependence liability.Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats.A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses.
P2860
Q24649537-15E6C52F-92CE-4B73-843C-53A2AAB789CDQ27312608-1C763962-862C-4EF6-BC16-F33E4110475EQ28297686-F2AD9EE3-820A-4D56-AB7B-0C84FD345305Q30437236-BDBCCCF0-BAEA-4944-AC12-94FB5DD9CA93Q30458743-EDCAC24C-3705-42A6-8C73-35F1447D7D55Q30480008-D971B1D1-3A50-419C-A095-4B55F82D55F2Q34268331-78E64256-2BD4-49F7-B714-C4FC083C45B4Q34423181-F6041A30-FD45-4C43-862C-997EB428F1B5Q34510753-42D53CD5-E86B-4A12-AB32-914323223BC4Q35026981-E8A4C08C-BEB8-4D57-B6DB-9038B83C6141Q35243402-D66D9A72-8C01-4961-A1D2-5E2C0DDC51A6Q35848930-F42A7C26-A4BA-4356-81B6-147333A5B217Q35989343-22A6CC43-FCAD-41EC-9302-67371490201BQ36104010-7732EB11-53C9-48FB-915A-C34A8206B379Q36232833-6111A170-4CB6-45CF-B1F6-97E8516FBDD1Q36456876-528B354C-2E91-482E-976E-68EAC82A2707Q36521971-138C6323-AB28-4BEE-A075-0F9D3DAA8F8EQ36605104-D3C64E5F-B77D-469A-88BB-7AD24CFF8005Q36744366-4BA002A4-11D3-4AB2-9C96-11583D56DD8EQ37143570-5592D392-616F-4B18-A530-B92B68F8F897Q37211503-D8227D12-188F-493E-92F2-0D398E9D27F4Q37444456-6749AA5C-F903-4577-AA2A-DDFD1E862AD5Q37444462-BC5DEF2D-FDA4-4935-B3AD-D47464AC1F0BQ37772519-CFB1D7F8-B6FD-4608-A8DB-57889F53F37EQ41453434-D0C2018C-662F-4FA3-9046-60F5388A430BQ41525142-0019ACAC-5A0F-4234-BBDD-2B5A420D44EBQ44350771-1DF28ED4-8189-4897-8488-93E483671521Q44350826-2BF4A59C-F6F7-4DC9-9F34-BF40AE79C76CQ44474417-4BFAB0EF-00A1-4ADA-803F-FCA7D20A1C02Q48107130-D3F7D1E1-148A-40E8-8EF0-8CE4A7D1E3DCQ48157771-83E03FD2-20CB-40E6-8073-4894ED4C7FA3
P2860
The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
The effect of a systemically a ...... conditioned place preference.
@ast
The effect of a systemically a ...... conditioned place preference.
@en
The effect of a systemically a ...... conditioned place preference.
@nl
type
label
The effect of a systemically a ...... conditioned place preference.
@ast
The effect of a systemically a ...... conditioned place preference.
@en
The effect of a systemically a ...... conditioned place preference.
@nl
prefLabel
The effect of a systemically a ...... conditioned place preference.
@ast
The effect of a systemically a ...... conditioned place preference.
@en
The effect of a systemically a ...... conditioned place preference.
@nl
P2093
P1433
P1476
The effect of a systemically a ...... conditioned place preference.
@en
P2093
James R Shoblock
Jürgen Wichmann
Nigel T Maidment
P304
P356
10.1016/J.NEUROPHARM.2005.04.008
P577
2005-09-01T00:00:00Z